Author(s): Dnyanda Kangude, S. D. Mankar

Email(s): sdmankar655@gmail.com

DOI: 10.52711/2231-5691.2023.00050   

Address: Dnyanda Kangude, S. D. Mankar
Pravara Rural College of Pharmacy, Pravaranagar.
*Corresponding Author

Published In:   Volume - 13,      Issue - 4,     Year - 2023


ABSTRACT:
The aim of this review is to discuss the influenza A i.e H3N2 influenza virus with their characteristics. Here we present the outline of the treatment regarding the H3N2 infection, precautions to be taken. The review focused on the symptoms and prevention of H3N2 influenza virus infection. It also highlites on the recent changes in new H3N2 influenza virus and focused on vaccinations against influenza, which researchers are currently developing to study these virus. Moreover this review states that the H3N2 influenza virus are rapidly altered themselves in different ways. The study also shows that the biology of influenza and adaptation acquired by new H3N2 influenza A virus create difficulties in future and current also to predicting the changes. Study of viral growth and their transmition. This review provides support and guide the researcher in the study and better understanding of influenza viruses.


Cite this article:
Dnyanda Kangude, S. D. Mankar. A Review on H3N2 Influenza Virus. Asian Journal of Pharmaceutical Research. 2023; 13(4):277-0. doi: 10.52711/2231-5691.2023.00050

Cite(Electronic):
Dnyanda Kangude, S. D. Mankar. A Review on H3N2 Influenza Virus. Asian Journal of Pharmaceutical Research. 2023; 13(4):277-0. doi: 10.52711/2231-5691.2023.00050   Available on: https://asianjpr.com/AbstractView.aspx?PID=2023-13-4-11


REFERENCES:
1.    Allen JD, Ross TM (2018) H3N2 influenza viruses in humans: viral mechanisms, evolution, and evaluation. Hum Vaccin Immun Other. 14:1840–1847.
2.    Barr IG, McCauley J, Cox N, Daniels R, Engelhardt OG, Fukuda K, Grohmann G, Hay A, Kelso A, Klimov A, Odagiri T (2010) Epidemiological, antigenic and genetic characteristics of seasonal influenza A (H1N1), A (H3N2) and B influenza viruses: basis for the WHO recommendation on the composition of influenza vaccines for use in the 2009–2010 Northern Hemisphere season. Vaccine. 28:1156–1167.
3.    Castro LA, Bedford T, Meyers LA (2020) Early prediction of antigenic transitions for influenza A/H3N2. PLOS Comput Biol. 16:e1007683.
4.    Chauhan N, Narang J, Pundir S, Singh S, Pundir CS (2013) Laboratory diagnosis of swine flu: a review. Artif Cells Nanomed Biotechnol. 41:189–195.
5.    Cui D, Zhao D, Xie G, Yang X, Huo Z, Zheng S, Yu F, Chen Y (2016) Simultaneous detection of influenza A subtypes of H3N2 virus, pandemic (H1N1) 2009 virus and reassortant avian H7N9 virus in humans by multiplex one-step real-time RT-PCR assay. Springerplus. 5:4–11.
6.    Dziąbowska K, Czaczyk E, Nidzworski D (2018) Detection methods of human and animal influenza virus-current trends. Biosensors. 8:94.
7.    Gavin PJ, Thomson RB Jr (2004) Review of rapid diagnostic tests for influenza. Clin Appl Immunol Rev. 4:151–172.
8.    Jang S, Choi H, Jung Y, Moon E, Yoon T (2016) A Comparison of H1N1 and H3N2 viruses using decision tree and apriori algorithm. Int J Mach Learn Cyb. 6(1):76.
9.    Kaji M, Watanabe A, Aizawa H (2003) Differences in clinical features between influenza A H1N1, A H3N2, and B in adult patients. Respirology. 8(2):231–233.
10.    Vemula SV, Zhao J, Liu J, Wang X, Biswas S, Hewlett I. Current approaches for diagnosis of influenza virus infections in humans. Viruses. 2016;8(4):96. doi:10.3390/v8040096..
11.    Van Baalen CA, Jeeninga RE, Penders GH, van Gent B, van Beek R, Koopmans MP, Rimmelzwaan GF. ViroSpot microneutralization assay for antigenic characterization of human influenza viruses. Vaccine. 2017;35(1):46–52. doi:10.1016/j.vaccine.2016.11.060.
12.    Bouvier NM and Palese P. The biology of influenza viruses. Vaccine. 2008;26:D49−53. doi: 10.1016/j.vaccine.2008.07.039.
13.    Westgeest KB, Russell CA, Lin X, Spronken MI, Bestebroer TM, Bahl J, van Beek R, Skepner E, Halpin RA, de Jong JC, et al., Genomewide analysis of reassortment and evolution of human influenza A (H3N2) viruses circulating between 1968 and 2011. J Virology. 2014;88(5):2844–57. doi: 10.1128/JVI.02163-13.
14.    Asaoka N, Tanaka Y, Sakai T, Fujii Y, Ohuchi R, Ohuchi M. Low growth ability of recent influenza clinical isolates in MDCK cells is due to their low receptor binding affinities. Microbes Infect. 2006;8(2):511–9. doi: 10.1016/j.micinf.2005.08.006.
15.    James D. Allena and Ted M. Rossa, B. Hum Vaccin Immunother. 2018; 14(8): 1840–1847.
16.    R. Dolin, “Te quadrivalent approach to infuenza vaccination,”Te Journal of Infectious Diseases, vol. 208, no. 4, pp. 539-540,2013.
17.    M. A. Keller and E. R. Stiehm, “Passive immunity in prevention and treatment of infectious diseases,” Clinical Microbiology Reviews, vol. 13, no. 4, pp. 602–614, 2000.
18.    J. Li and Z. Zhu, “Research and development of next generation of antibody-based therapeutics,” Acta Pharmacologica Sinica,vol. 31, no. 9, pp. 1198–1207, 2010.
19.    A. Casadevall, “Antibody-based therapies for emerging infectious diseases,” Emerging Infectious Diseases, vol. 2, no. 3, pp.200–208, 1996.
20.    Medeiros R, Escriou N, Naffakh N, Manuguerra JC, van der Werf S (2001) Hemagglutinin residues of recent human A (H3N2) influenza viruses that contribute to the inability to agglutinate chicken erythrocytes. Virology 289:74–85.
21.    Oh DY, Barr IG, Mosse JA, Laurie KL (2008) MDCK-SIAT1 cells show improved isolation rates for recent human influenza viruses compared to conventional MDCK cells. J Clin Microbiol 46:2189–2194.
22.    J. Y. Kim, Y. G. Kim, and G. M. Lee, “CHO cells in biotechnology for production of recombinant proteins: Current state and further potential,” Applied Microbiology and Biotechnology, vol.93, no. 3, pp. 917–930, 2012.
23.    A. Y. Zvonarjev and Y. Z. Ghendon, “Infuence of membrane (M) protein on infuenza A virus virion transcriptase activity in vitro and its susceptibility to rimantadine,” Journal of Virology, vol. 33, no. 2, pp. 583–586, 1980
24.    Claas E C, Osterhaus A D, van Beek R, de Jong J C, Rimmelzwaan G F, Senne D A, Krauss S, Shortridge K F, Webster R G. Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus. Lancet. 1998;351:472–477
25.    D. M. Skowronski, G. de Serres, N. S. Crowcrof et al., “Association between the 2008-09 seasonal infuenza vaccine and pandemic H1N1 illness during spring-summer 2009: four observational studies from Canada,” PLoS Medicine, vol. 7, no.4, 2010.
26.    C. Wesselhoef, “Treatment of scarlet fever and diphtheria,”Medical Clinics of North America Journal, vol. 19, pp. 1389–1407,1936.
27.    M. A. Keller and E. R. Stiehm, “Passive immunity in preventionand treatment of infectious diseases,” Clinical Microbiology Reviews, vol. 13, no. 4, pp. 602–614, 2000.
28.    Pansaert M, Ottis K, Vandeputte J, Kaplan M M, Bachmann P A. Evidence of natural transmission of influenza A virus from wild ducks to swine and its potential importance for man. Bull W H O. 1996;59:75–78.
29.    Hinshaw V S, Bean W J, Jr, Webster R G, Easterday B C. The prevalence of influenza viruses in swine and the antigenic and genetic relatedness of influenza viruses from man and swine. Virology. 1978;84:51–62.
30.     Beare A S, Webster R G. Replication of avian influenza viruses in humans. Arch Virol. 1991;119:37–42.
31.    http://www.cdc.gov/fu/avianfu/infuenza-a-virus-subtypes.htm.
32.    S. Khurana, C. L. Loving, J. Manischewitz et al., “Vaccine induced anti-HA2 antibodies promote virus fusion and enhance infuenza virus respiratory disease,” Science Translational Medicine, vol. 5, no. 200, Article ID 200ra114, 2013.


Recomonded Articles:

Author(s): Ravi Kumar, Komal

DOI: 10.5958/2231-5691.2021.00003.4         Access: Open Access Read More

Author(s): Ashok Thulluru, Nawaz Mahammed, C. Madhavi, K. Nandini, S. Sirisha, D. Spandana

DOI: 10.5958/2231-5691.2019.00016.9         Access: Open Access Read More

Author(s): Rutuja R. Shah, Rohan R. Vakhariya

DOI: 10.5958/2231-5691.2020.00003.9         Access: Open Access Read More

Author(s): B.A. Bhairav, J.K. Bachhav, R.B. Saudagar

DOI: 10.5958/2231-5691.2016.00025.3         Access: Open Access Read More

Author(s): Sandesh Narayan Somnache, Ajeet Madhukar Godbole, Pankaj Sadashiv Gajare, Sapna Kashyap

DOI: 10.5958/2231-5691.2016.00028.9         Access: Open Access Read More

Author(s): Ghanshyam Dhalendra, Trilochan Satapathy, Amit Roy

DOI:         Access: Open Access Read More

Author(s): Lalita Balasaheb Patil, Swapnil S. Patil, Manoj M. Nitalikar, Chandrakant S. Magdum, Shrinivas K. Mohite

DOI: 10.5958/2231-5691.2016.00030.7         Access: Open Access Read More

Author(s): Bijay Kumar Sahoo, Sidheswar Prasad Pattajoshi, Sandhyarani Pattajoshi

DOI: 10.5958/2231-5691.2018.00011.4         Access: Open Access Read More

Author(s): Gawai Mamata N., Aher Smita S, Saudager Ravindra B.

DOI:         Access: Open Access Read More

Author(s): Ashok Thulluru, C. Madhavi, K. Nandini, S. Sirisha, D. Spandana

DOI: 10.5958/2231-5691.2019.00041.8         Access: Open Access Read More

Author(s): Anuradha V. P, Betsy Joseph, Jayakrishnan S. S, Ajith B

DOI: 10.5958/2231-5691.2019.00033.9         Access: Open Access Read More

Author(s): Madhanraj P., Nadimuthu, N., Panneerselvam A.

DOI:         Access: Open Access Read More

Author(s): S. Sujani, R. Hari Babu , K. Ravindra Reddy

DOI:         Access: Open Access Read More

Author(s): Nikita D. Gidde, Indrayani D. Raut, Manojkumar M. Nitalikar, Shrinivas K. Mohite, Chandrakant S. Magdum

DOI: 10.52711/2231-5691.2021.00023         Access: Open Access Read More

Author(s): Sumithra P., Viji T., Madhanraj P., N. Nadimuthu

DOI: 10.5958/2231-5691.2015.00004.0         Access: Open Access Read More

Author(s): Vaishnavi. K. Patil, Azam. Z. Shaikh

DOI: 10.5958/2231-5691.2020.00048.9         Access: Open Access Read More

Author(s): Earle Radha Rani, M. Ramadevi, Ayalasomayajula Lakshmi Usha

DOI: 10.5958/2231-5691.2021.00006.X         Access: Open Access Read More

Asian Journal of Pharmaceutical Research (AJPRes.) is an international, peer-reviewed journal, devoted to pharmaceutical sciences. AJPRes. publishes Original Research Articles, Short Communications..... Read more >>>

RNI: Not Available                     
DOI: 10.5958/2231–5691 


Recent Articles




Tags